ES2634613T3 - Métodos de obtención de leche estéril y composiciones de la misma - Google Patents

Métodos de obtención de leche estéril y composiciones de la misma Download PDF

Info

Publication number
ES2634613T3
ES2634613T3 ES07811645.6T ES07811645T ES2634613T3 ES 2634613 T3 ES2634613 T3 ES 2634613T3 ES 07811645 T ES07811645 T ES 07811645T ES 2634613 T3 ES2634613 T3 ES 2634613T3
Authority
ES
Spain
Prior art keywords
protein
fraction
milk
whole milk
skimmed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07811645.6T
Other languages
English (en)
Inventor
Elena Maria Medo
Armando Montoya
Martin L. Lee
David Rechtman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prolacta Bioscience Inc
Original Assignee
Prolacta Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prolacta Bioscience Inc filed Critical Prolacta Bioscience Inc
Application granted granted Critical
Publication of ES2634613T3 publication Critical patent/ES2634613T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/20Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/206Colostrum; Human milk
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C3/00Preservation of milk or milk preparations
    • A23C3/02Preservation of milk or milk preparations by heating
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/14Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1422Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C2210/00Physical treatment of dairy products
    • A23C2210/25Separating and blending
    • A23C2210/252Separating a milk product in at least two fractions followed by treatment of at least one of the fractions and remixing at least part of the two fractions

Landscapes

  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Water Supply & Treatment (AREA)
  • Dairy Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Un método para la obtención de una composición de leche humana que comprende: (a) filtración de leche entera agrupada a través de un filtro de 100-400 micrómetros; (b) tratamiento térmico de la leche entera a 58-65 °C durante 20-40 minutes; (c) separación de la leche entera en una porción desnatada y una porción de grasa; (d) ultrafiltración de la porción desnatada a través de uno o más ultrafiltros para obtener una porción permeada y una fracción retenida desnatada rica en proteínas; (e) mezclado de una fracción de la porción de grasa con la fracción retenida desnatada rica en proteínas para obtener una composición de leche humana.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
12
imagen12
imagen13
imagen14

Claims (11)

  1. REIVINDICACIONES
    1. Un método para la obtención de una composición de leche humana
    que comprende: 5
    (a)
    filtración de leche entera agrupada a través de un filtro de 100-400 micrómetros;
    (b)
    tratamiento térmico de la leche entera a 58-65 °C durante 20-40 minutes;
    (c)
    separación de la leche entera en una porción desnatada y una porción de grasa;
    (d) ultrafiltración de la porción desnatada a través de uno o más ultrafiltros para obtener una porción permeada y 10 una fracción retenida desnatada rica en proteínas;
    (e) mezclado de una fracción de la porción de grasa con la fracción retenida desnatada rica en proteínas para obtener una composición de leche humana.
  2. 2. El método de la reivindicación 1, que comprende además el análisis de una muestra de la leche entera para 15 determinar la presencia de VIH1, VIH2, VHB, VHC, HTLVI, HTLVII, sífilis y B. cereus antes de la filtración.
  3. 3. El método de la reivindicación 1, en el que el filtrado de la leche entera en la etapa (a) se realiza a través de un tamiz de filtro de 200 micrómetros.
    20 4. El método de la reivindicación 1, en el que el tratamiento térmico de la leche entera en la etapa (b) se realiza a 63 °C durante 30 minutos.
  4. 5. El método de la reivindicación 1 en el que la porción de grasa obtenida en la etapa (c) se sigue procesando para
    obtener una porción de leche desnatada adicional. 25
  5. 6. El método de la reivindicación 5, en el que la porción desnatada adicional se agrupa con la porción desnatada obtenida en la etapa (c).
  6. 7. El método de la reivindicación 1, que comprende además recoger y filtrar la fracción permeada obtenida en la 30 etapa (d) para obtener una segunda fracción retenida.
  7. 8. El método de la reivindicación 7 en el que la segunda fracción retenida se añade a la primera fracción retenida obtenida en la etapa (d) de la reivindicación 1.
    35 9. El método de la reivindicación 1 en el que la ultrafiltración utiliza una membrana de ultrafiltración que impide el paso de cualquier sustancia con un peso molecular superior a 1-40 kDa.
  8. 10. El método de las reivindicaciones 1 o 7 que comprende además el lavado de los ultrafiltros con la fracción
    permeada obtenida en la etapa (d) de la reivindicación 1 para obtener un lavado de proteína y la adición del lavado 40 de proteína a la fracción retenida desnatada rica en proteína obtenida en la etapa (d).
  9. 11. El método de la reivindicación 1 en el que tras la pasteurización, se analiza la leche pasteurizada para determinar el contenido nutricional, el contenido de proteínas, los factores específicos y se ajusta a un nivel deseado.
    45
  10. 12. El método de la reivindicación 1, en el que se pasteuriza la composición de leche humana obtenida en la etapa (e).
  11. 13. Una composición de leche humana obtenida según el método de una cualquiera de las reivindicaciones 50 anteriores que comprende:
    (a)
    un constituyente de proteína de 20-70 mg/ml;
    (b)
    un constituyente de grasa de 35-85 mg/ml,
    (c) un constituyente de hidratos de carbono de 70-115 mg/ml. 55
    16
ES07811645.6T 2006-08-30 2007-08-30 Métodos de obtención de leche estéril y composiciones de la misma Active ES2634613T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US84137106P 2006-08-30 2006-08-30
US841371P 2006-08-30
US86774806P 2006-11-29 2006-11-29
US867748P 2006-11-29
PCT/US2007/019234 WO2008027572A1 (en) 2006-08-30 2007-08-30 Methods of obtaining sterile milk and compositions thereof

Publications (1)

Publication Number Publication Date
ES2634613T3 true ES2634613T3 (es) 2017-09-28

Family

ID=39136247

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07811645.6T Active ES2634613T3 (es) 2006-08-30 2007-08-30 Métodos de obtención de leche estéril y composiciones de la misma

Country Status (6)

Country Link
US (7) US9149052B2 (es)
EP (1) EP2063722B1 (es)
JP (2) JP5448819B2 (es)
ES (1) ES2634613T3 (es)
PT (1) PT2099321T (es)
WO (1) WO2008027572A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020182243A1 (en) 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
WO2007035870A2 (en) 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. A method for testing milk
CA2706722C (en) 2006-11-29 2016-01-12 Prolacta Bioscience, Inc. Human milk compositions and methods of making and using same
JP5616066B2 (ja) 2006-12-08 2014-10-29 プロラクタ バイオサイエンス,インコーポレイテッド ヒト脂質組成物ならびにその製造および使用方法
US8927027B2 (en) 2008-12-02 2015-01-06 Prolacta Bioscience Human milk permeate compositions and methods of making and using same
CN103987265B (zh) 2011-08-03 2017-05-24 普罗莱克塔生物科学公司 减少细菌污染的人乳微滤
MX354727B (es) * 2011-10-18 2018-03-16 Nestec Sa Composicion para uso en la promocion de absorcion de magnesio y/o retencion de magnesio.
US9458230B2 (en) * 2013-01-04 2016-10-04 Wisconsin Alumni Research Foundation Secretory IGA compositions, methods of making and methods of use thereof
US20140271980A1 (en) * 2013-03-13 2014-09-18 Prolacta Bioscience Adulteration testing of human milk
ES2843254T3 (es) 2013-03-13 2021-07-16 Prolacta Bioscience Inc Productos de leche humana rica en grasas
ITMI20131690A1 (it) * 2013-10-14 2015-04-15 Consiglio Nazionale Ricerche Composizione alimentare.
US20170367364A1 (en) * 2014-12-30 2017-12-28 Prolacta Bioscience. Inc. Methods of preventing and treating bronchopulmonary dysplasia using high fat human milk products
EP3397064A4 (en) 2015-12-30 2019-10-30 Prolacta Bioscience, Inc. HUMAN MILK PRODUCTS USEFUL IN PRE- AND POST-OPERATIVE CARE
SG11201902969VA (en) * 2016-10-04 2019-05-30 Imb Inc Methods and systems for generating a sterilized human milk product
WO2020123121A1 (en) * 2018-12-11 2020-06-18 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods of screening antibodies for treating and/or preventing necrotizing enterocolitis (nec)
US12070044B2 (en) 2019-02-22 2024-08-27 Aquero Canada Ltd. Fortified milk compositions and their processes of preparation
BR112022005578A2 (pt) 2019-09-24 2022-09-20 Prolacta Bioscience Inc Composições e métodos para tratamento de doenças inflamatórias e imunes
WO2021146561A1 (en) 2020-01-17 2021-07-22 Prolacta Bioscience, Inc. Feeding protocol for optimal growth of preterm infants
CN116322371A (zh) 2020-08-14 2023-06-23 普罗莱克塔生物科学公司 与细菌疗法一起使用的人乳寡糖组合物
KR20230131228A (ko) 2021-01-12 2023-09-12 프롤랙타 바이오사이언스, 인코포레이티드 신바이오틱 치료 요법
CA3205754A1 (en) 2021-01-22 2022-07-28 Biranchi Patra Topical human milk formulations
WO2024130119A2 (en) 2022-12-16 2024-06-20 Prolacta Bioscience, Inc. Synbiotic compositions for short chain fatty acid production

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2148100A (en) * 1936-07-01 1939-02-21 M & R Dietetic Lab Inc Treatment of milk fluids
JPS5948964B2 (ja) * 1978-01-11 1984-11-30 雪印乳業株式会社 人乳に類似した育児用乳の製造法
JPS6133895Y2 (es) * 1980-02-29 1986-10-03
US4462932A (en) * 1983-06-22 1984-07-31 Purdue Research Foundation Isolation of native casein by cryodestabilization
JPS6467141A (en) * 1987-09-08 1989-03-13 Kougakushiya Kk Method for removing various germs and somatic cell from cow's milk and apparatus therefor
JP3061649B2 (ja) * 1991-02-08 2000-07-10 森永乳業株式会社 抗アレルギー性調製乳
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
JP3150504B2 (ja) * 1993-02-26 2001-03-26 雪印乳業株式会社 低乳糖乳製品およびその製造方法
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
US5670196A (en) * 1995-04-12 1997-09-23 Galagen Inc. Method for microfiltration of milk or colostral whey
JPH09275897A (ja) * 1996-04-16 1997-10-28 Takamichi Tominaga ミルクの調整法及び粉ミルク計量器及び粉ミルク計量器の組合せ
US6194009B1 (en) * 1996-11-22 2001-02-27 Princeton Nutrition, Llc Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula
US6652900B2 (en) 1997-03-14 2003-11-25 Tetra Laval Holdings & Finance S.A. Method and plant for producing a sterile milk product
NL1010829C2 (nl) * 1998-12-16 2000-06-19 Prolion Bv Inrichting en werkwijze voor het melken van dieren en een vervuilingsmeter.
US6294206B1 (en) * 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
WO2001036442A1 (en) * 1999-11-17 2001-05-25 Jiuping Ji Simultaneous detection of hbv, hcv and hiv in plasma samples using a multiplex capture assay
US6932967B2 (en) * 2001-03-22 2005-08-23 Michael R. Simon Human medical treatment by aerosol inhalation of immunoglobulin A
WO2002090572A2 (en) * 2001-05-09 2002-11-14 Third Wave Technologies, Inc. Nucleic acid detection in pooled samples
US20020182243A1 (en) * 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
US20070196506A2 (en) * 2002-02-04 2007-08-23 Bristol-Myers Squibb Company Improved tolerance nutritional product to supplement human milk
FI115752B (fi) * 2002-05-14 2005-07-15 Valio Oy Menetelmä käytettäväksi vähälaktoosisen tai laktoosittoman maitotuotteen valmistamiseksi
NZ527434A (en) * 2003-08-07 2006-03-31 Fonterra Co Operative Group Production of protein composition from a dairy stream and its use as an ingredient in the manufacture of a cheese
EP1787114A1 (en) * 2004-09-10 2007-05-23 Medela Holding AG Method for analysing and treating human milk and system therefore
EP1637043A1 (en) * 2004-09-17 2006-03-22 Medela Holding AG Human milk fortifiers and methods for their production
US20080187619A1 (en) * 2004-09-10 2008-08-07 Medela Holding Ag Human Milk Fortifiers and Methods for Their Production

Also Published As

Publication number Publication date
WO2008027572A1 (en) 2008-03-06
US20160050949A1 (en) 2016-02-25
US20190053508A1 (en) 2019-02-21
EP2063722B1 (en) 2017-05-03
US20170347675A1 (en) 2017-12-07
JP2012231793A (ja) 2012-11-29
PT2099321T (pt) 2017-07-21
US20190327994A1 (en) 2019-10-31
US9149052B2 (en) 2015-10-06
JP2010502186A (ja) 2010-01-28
JP5770690B2 (ja) 2015-08-26
JP5448819B2 (ja) 2014-03-19
EP2063722A4 (en) 2011-05-18
EP2063722A1 (en) 2009-06-03
US20190075809A1 (en) 2019-03-14
US20220232844A1 (en) 2022-07-28
US20110256269A1 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
ES2634613T3 (es) Métodos de obtención de leche estéril y composiciones de la misma
Giangrande Six characters in search of an author: the history of the nomenclature of coagulation factors.
Kodavanti et al. The spontaneously hypertensive rat as a model of human cardiovascular disease: evidence of exacerbated cardiopulmonary injury and oxidative stress from inhaled emission particulate matter
Burt et al. Does low birthweight increase the risk of caries? A systematic review
Florén et al. ColoPlus, a new product based on bovine colostrum, alleviates HIV-associated diarrhoea
Cameron et al. The clinical association of macrocytic anemia with intestinal stricture and anastomosis
Parsons Celiac Disease: Rachford Memorial Lectures
ES2234552T3 (es) Un metodo para tratamiento de calostro.
Vanholder et al. Endotoxin transfer through dialysis membranes: small-versus large-pore membranes
UA52601C2 (uk) Спосіб виробництва питного молока з тривалим терміном зберігання
RU2016114740A (ru) Способ гуманизирования обезжиренного молока животных
Prasongwatana et al. Chemical components of urinary stones according to age and sex of adult patients
Todd et al. On the haemolytic immune isolysins of the ox and their relation to the question of individuality and blood-relationship
Emektar et al. Determination of factors associated with perforation in patients with geriatric acute appendicitis
Datta et al. Microalbuminuria as a predictor of early glomerular injury in children with sickle cell disease
World Health Organization Global measles and rubella laboratory network—update
Al Hadidi et al. Loeffler's syndrome secondary to hyperinfection by Strongyloides stercoralis associated with methotrexate in a patient with rheumatoid arthritis
Garrido-Castañé et al. Cardiopulmonary helminths in foxes from the Pyrenees
Wesołowska et al. Concurrent infection of a young tourist by hookworm and during low budget travel in Southeast Asia
El-Mandrawy et al. Molecular Characterization, Hematological and Biochemical Studies on Foot and Mouth Disease Virus Serotype O in Buffaloes and Cows in Dakahlia Governorate, Egypt
Yıldız et al. Epidemiological, laboratory and clinical features of childhood hydatid disease
Porter Remarks on intestinal parasites in Montreal, and the relation of Entamoeba histolytica to colitis
Jorfizadeh et al. Relationships of Students’ Mental Well-being with Mothers’ Emotional Breakdown and Marital Justice Mediated by Mothers’ Marital Intimacy
Olaru et al. „GASTRITIS” MASKING LATE SYMPTOMS OF MUSHROOM POISONING IN A TEENAGER.
JP2017525349A (ja) 個人別濃縮人乳組成物の製造のための装置及びキット、並びにその製造及び使用方法